Biology says "continue." Economics says "stop."
What happens when older adults lose weight and critical muscle mass on GLP-1s, only to lose access when Medicare's funding bridge ends in 2027?
I ran the numbers. We are engineering a massive frailty crisis.
bio-logik-al.com
The GLP-1 Exit Problem
GLP-1 drugs work. Roughly 3–4 million Americans over 65 may be heading for the part nobody has studied: rapid weight loss, some muscle lost along with it, discontinuation, and substantial regain.